 | | PRD_002430 | | Name: | Darobactin 9 | | Formula: | C49 H57 N12 O12 | | Definition date: | 2023-01-11 | | Last modified: | 2023-01-11 |
|
 | | PRD_002415 | | Name: | 3'-sialyl-beta-lactose | | Formula: | C23 H39 N O19 | | Description: | oligosaccharide | | Definition date: | 2022-12-21 | | Last modified: | 2022-12-21 |
|
 | | PRD_002411 | | Name: | peptide BOC-GLY-PHE-HIS-H | | Formula: | C22 H30 N5 O5 | | Definition date: | 2022-12-07 | | Last modified: | 2022-12-07 |
|
 | | PRD_002412 | | Name: | peptide OCA-GLY-PHE-HIS-H | | Formula: | C25 H36 N5 O4 | | Definition date: | 2022-12-07 | | Last modified: | 2022-12-07 |
|
 | | PRD_002413 | | Formula: | C19 H24 N5 O4 | | Definition date: | 2022-11-30 | | Last modified: | 2022-11-30 |
|
 | | PRD_002043 | | Name: | Goblin1 | | Formula: | C34 H60 N8 O12 | | Definition date: | 2013-12-04 | | Last modified: | 2022-10-29 |
|
 | | PRD_002086 | | Formula: | C24 H34 N4 O8 | | Definition date: | 2013-10-02 | | Last modified: | 2022-10-29 |
|
 | | PRD_002379 | | Name: | thiopeptide TP1 | | Formula: | C83 H108 N19 O17 S2 | | Definition date: | 2022-10-26 | | Last modified: | 2022-10-26 |
|
 | | PRD_002381 | | Name: | thiopeptide TP15 | | Formula: | C77 H115 N26 O17 S3 | | Definition date: | 2022-10-26 | | Last modified: | 2022-10-26 |
|
 | | PRD_002409 | | Name: | UDP-MurNAc-pentapeptide | | Formula: | C37 H58 N8 O26 P2 S | | Description: | Peptidoglycan precursor analogue | | Definition date: | 2022-10-26 | | Last modified: | 2022-10-26 |
|
 | | PRD_002097 | | Name: | [[[(4S)-5-[[(2S)-1-[[(2S)-5-[[azaniumylidene(azanyl)methyl]amino]-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-5-oxidanylidene-4-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoylamino]pentyl]amino]-azanyl-methylidene]azanium | | Formula: | C27 H46 N10 O6 | | Description: | Acts as a reversible inhibitor of serine/cysteine proteases and some trypsin-like serine proteases. | | Definition date: | 2013-08-07 | | Last modified: | 2022-10-20 |
|
 | | PRD_002509 | | Name: | Colistin | | Formula: | C52 H98 N16 O13 | | Definition date: | 2022-09-14 | | Last modified: | 2022-09-14 |
|
 | | PRD_002370 | | Name: | Taltirelin | | Formula: | C17 H24 N7 O5 | | Definition date: | 2022-08-31 | | Last modified: | 2022-08-31 |
|
 | | PRD_002371 | | Name: | Endogenous Peptide Agonist TRH | | Formula: | C16 H23 N6 O4 | | Definition date: | 2022-08-31 | | Last modified: | 2022-08-31 |
|
 | | PRD_002386 | | Name: | tert-butyl N-[3-(2-hydroxyethylcarbamoyl)-5-phenyl-thiophen-2-yl]carbamate | | Formula: | C18 H22 N2 O4 S | | Definition date: | 2022-08-31 | | Last modified: | 2022-08-31 |
|
 | | PRD_002490 | | Name: | Eptifibatide | | Formula: | C35 H49 N11 O9 S2 | | Definition date: | 2022-08-17 | | Last modified: | 2022-08-17 |
|
 | | PRD_002496 | | Name: | evybactin | | Formula: | C64 H91 N21 O21 | | Definition date: | 2022-08-17 | | Last modified: | 2022-08-17 |
|
 | | PRD_002491 | | Name: | Sa-D2 | | Formula: | C88 H122 N19 O23 S2 | | Definition date: | 2022-08-10 | | Last modified: | 2022-08-10 |
|
 | | PRD_002492 | | Name: | Sa-D3 | | Formula: | C87 H110 N18 O24 S | | Definition date: | 2022-08-10 | | Last modified: | 2022-08-10 |
|
 | | PRD_002367 | | Name: | ~{N}-[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]-1-methyl-4-[3-[[1-methyl-4-[[1-methyl-4-[3-[[1-methyl-4-[(1-methylimidazol-2-yl)carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazol-2-yl]carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazole-2-carboxamide | | Formula: | C41 H55 N17 O8 | | Definition date: | 2022-08-03 | | Last modified: | 2022-08-03 |
|
 | | PRD_002384 | | Formula: | C58 H95 N15 O15 | | Definition date: | 2022-08-03 | | Last modified: | 2022-08-03 |
|
 | | PRD_000468 | | Name: | Allosamidin | | Formula: | C25 H42 N4 O14 | | Definition date: | 2015-07-18 | | Last modified: | 2022-03-03 |
|
 | | PRD_002479 | | Name: | Cyclic Peptide Inhibitor ZO1-GLN-SER-TPO-45W-MLL | | Formula: | C34 H48 F3 N6 O14 P | | Definition date: | 2022-03-02 | | Last modified: | 2022-03-02 |
|
 | | PRD_000204 | | Name: | Vancomycin | | Formula: | C66 H75 Cl2 N9 O24 | | Description: | VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. | | Definition date: | 2012-12-12 | | Last modified: | 2022-01-06 |
|
 | | PRD_002455 | | Name: | D-PMI-omega | | Formula: | C82 H115 Cl N17 O20 | | Definition date: | 2021-11-17 | | Last modified: | 2021-11-17 |
|
